Skip to search formSkip to main contentSkip to account menu

CVT 3619

Known as: CVT-3619, CVT3619 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A novel hybrid-excited flux-modulated memory machine for electrical continuously variable transmission system
This paper proposed a hybrid-excited double rotor double stator permanent magnetic machine applied in electrical continuously… 
2011
2011
Partial adenosine A1 receptor agonists for cardiovascular therapies
Adenosine, a purine nucleoside, is present in all cells in tightly regulated concentrations. It has many different physiological… 
2009
2009
Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats
Introduction and Aims:  Elevated plasma free fatty acid (FFA) concentrations play a role in the pathogenesis of type 2 diabetes… 
Review
2008
Review
2008
A1 adenosine receptor agonists and their potential therapeutic applications
Background: The challenges in developing any A1 adenosine receptor (A1-AdoR) agonist involve having the desired effect on target… 
Highly Cited
2007
Highly Cited
2007
Antilipolytic Activity of a Novel Partial A1 Adenosine Receptor Agonist Devoid of Cardiovascular Effects: Comparison with Nicotinic Acid
Elevated lipolysis and circulating free fatty acid (FFA) levels have been linked to the pathogenesis of insulin resistance. A1… 
2006
2006
A Novel Partial Agonist of the A1 -Adenosine Receptor and Evidence of Receptor Homogeneity in Adipocytes
This study characterizes the receptor binding and functional effects of CVT-3619 [2-{6-[((1R,2R)-2-hydroxycyclopentyl)-amino… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)